Suzhou Siran Biotechnology Co.,ltd.

This early-stage study tests a new medicine called SA1211, given as a shot under the skin. It first checks safety in healthy volunteers, then looks at how well it works in people with chronic hepatitis B. The goal is to see if the drug can help control the virus. About 80 people …